Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 12, 2019

SELL
$15.58 - $20.01 $62,678 - $80,500
-4,023 Closed
0 $0
Q4 2018

Jan 29, 2019

SELL
$14.59 - $23.84 $2,334 - $3,814
-160 Reduced 3.83%
4,023 $62,000
Q3 2018

Oct 24, 2018

BUY
$21.06 - $25.65 $3,369 - $4,104
160 Added 3.98%
4,183 $90,000
Q1 2018

Apr 16, 2018

BUY
$16.68 - $22.07 $63,767 - $84,373
3,823 Added 1911.5%
4,023 $69,000
Q4 2017

Jan 30, 2018

SELL
$11.23 - $19.1 $22,460 - $38,200
-2,000 Reduced 90.91%
200 $4,000
Q3 2017

Oct 10, 2017

BUY
$15.41 - $32.17 $33,902 - $70,774
2,200
2,200 $39,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ledyard National Bank Portfolio

Follow Ledyard National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.